Sökning: "Renal biomarkers"
Visar resultat 11 - 15 av 79 avhandlingar innehållade orden Renal biomarkers.
11. Tumor microenvironment derived biomarkers in renal cell cancer
Sammanfattning : Renal cell carcinoma (RCC) is the 13th most common malignancy worldwide, and constitutes around 2% of all malignant tumors. The entity renal cell carcinoma comprises a heterogenous group of malignant tumors that originates from the epithelial cells in the renal proximal tubule. LÄS MER
12. Aspects of renal blood flow and oxygenation in acute kidney injury during severe infections
Sammanfattning : Acute kidney injury (AKI) is a common complication in patients treated in the intensive care unit (ICU). Severe infections/sepsis is the most common aetiology, and about half of patients treated in the ICU due to sepsis are affected. Although AKI often resolves over time, the development of AKI decreases the chances of surviving. LÄS MER
13. Infants with urinary tract infection - renal damage and risk factors
Sammanfattning : Background Identification of infants with urinary tract infection (UTI) who are at risk of renal scarring is an important clinical challenge with considerable economic consequences. Few issues in pediatric practice today have been so debated as the appropriate investigation of an infant with UTI. LÄS MER
14. Biomarker discovery and assessment for prediction of kidney response after 177Lu-octreotate therapy
Sammanfattning : Patients suffering from neuroendocrine tumors are oftentimes presented with spread disease at the time of diagnosis. Therapy using somatostatin analogs is today the only potentially curative treatment option for these patients. LÄS MER
15. Biomarker Discovery in Cancer and Autoimmunity using an Affinity Proteomics Platform - a Tool for Personalized Medicine
Sammanfattning : Identification of novel biomarkers for early diagnosis, prognosis, and treatment decision will be instrumental for improving disease outcome for patients suffering from complex diseases, such as cancer and autoimmune disorders. Within personalized medicine, the use of circulating biomarkers will allow clinicians to tailor medical treatment based on individual characteristics of each patient, using minimally invasive sampling. LÄS MER